DNA DGCI approves Covaxin clinical trials for 2-18 year olds
The Drugs Controller General of India (DCGI) on Thursday (May 13) approved Bharat Biotech's covariate trials on children aged 2 to 18 years. Bharat Biotech said its Phase II and Phase III trials would be conducted on "525 healthy volunteers".
The Drugs Controller General of India (DCGI) on Thursday (May 13) approved Bharat Biotech's covariate trials on children aged 2 to 18 years. Bharat Biotech said its Phase II and Phase III trials would be conducted on "525 healthy volunteers".